BerandaRLF • SWX
add
RELIEF THERAPEUTICS Holding SA
Tutup sebelumnya
CHFÂ 2,36
Rentang hari
CHFÂ 2,31 - CHFÂ 2,49
Rentang tahun
CHFÂ 1,06 - CHFÂ 7,60
Kapitalisasi pasar
34,89Â jt CHF
Volume Rata-Rata
26,15Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
SWX
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CHF) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,38Â jt | -8,21% |
Biaya operasional | 2,63Â jt | -48,44% |
Laba bersih | -6,28Â jt | 69,86% |
Margin laba bersih | -454,65 | 67,17% |
Penghasilan per saham | — | — |
EBITDA | -1,45Â jt | 58,14% |
Tarif pajak efektif | 18,21% | — |
Neraca
Total aset
Total liabilitas
| (CHF) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 15,08Â jt | 3,54% |
Total aset | 53,22Â jt | -30,33% |
Total liabilitas | 16,56Â jt | -31,46% |
Total ekuitas | 36,66 jt | — |
Saham yang beredar | 12,54 jt | — |
Harga terhadap nilai buku | 0,81 | — |
Tingkat pengembalian aset | -7,07% | — |
Tingkat pengembalian modal | -9,70% | — |
Arus Kas
Perubahan kas bersih
| (CHF) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -6,28Â jt | 69,86% |
Kas dari operasi | 125,00Â rb | 103,50% |
Kas dari investasi | 2,20Â jt | -50,56% |
Kas dari pembiayaan | -123,00Â rb | -98,39% |
Perubahan kas bersih | 2,18Â jt | 146,71% |
Arus kas bebas | 1,25Â jt | -47,41% |
Tentang
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG and listed on the SIX Swiss Exchange in 2016. Wikipedia
Didirikan
2013
Karyawan
31
